medigraphic.com
Revista Médica Sinergia

2021, Number 11

<< Back Next >>

Revista Médica Sinergia 2021; 6 (11)

Psoriasis: overview

Hidalgo SMJ, Víquez RKF, Meneses CM

Language: Spanish
References: 25
Page:
PDF size: 214.60 Kb.


ABSTRACT

Psoriasis is a chronic immune disorder that develops after exposure to a skin lesion; either traumatic, medicinal or infectious in genetically predisposed people. It presents in a classic way as erythematous confluent plaques, micaceous scales with well-defined borders, however there are other clinical cutaneous forms. Beyond skin involvement, psoriasis is also associated with a number of important medical and psychiatric comorbidities, including psoriatic arthritis, cardiovascular disease, diabetes, malignancies, depression, and anxiety. Its treatment depends on the severity of the clinical picture, ranging from topical preparations to systemic treatments, without forgetting the multidisciplinary management of its comorbidities.


REFERENCES

  1. Christopher E M Griffiths, April W Armstrong, Johann E Gudjonsson, Jonathan N W N Barker. Psoriasis. Lancet 2021. 397: 1301–15

  2. Dr Stephen J Mounsey, Dr Elizabeth Kulakov. Psoriasis. British Journal of Hospital Medicine, August 2018, Vol 79, No 8

  3. Frank O. Nestle, M.D., Daniel H. Kaplan, M.D., Ph.D., and Jonathan Barker, M.D. Mechanisms of Disease: Psoriasis. The New England Journal of Medicine, 2009;361:496-509.

  4. Tokuyama, M., & Mabuchi, T. (2020). New Treatment Addressing the Pathogenesis of Psoriasis. International Journal of Molecular Sciences, 21(20), 7488. https://doi.org/10.3390/ijms21207488

  5. AprilW. Armstrong, MD, MPH; Charlotte Read, MBBS, BSc. JAMA May 19, 2020 Volume 323, Number 19. https://doi.org/10.1001/jama.2020.4006

  6. Luigi Naldi, MD, Daniele Gambini, MD. The clinical spectrum of psoriasis. Clinics in Dermatology, Volume 25, Issue 6, 2007. https://doi.org/10.1016/j.clindermatol.2007.08.003

  7. Todke, P. and Shah, V.H. (2018), Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches. Int J Dermatol, 57: 1387-1402. https://doi.org/10.1111/ijd.14047

  8. Dra. Natacha López Pupo, Dra. María Elena Tablada Robinet, Dra. Ana Lucía Jacas Portuondo, Dra. Adelina Baltazar Green, Dr. Luis Felipe González Vázquez. Factores de riesgo y comorbilidades en pacientes con psoriasis. MEDISAN 2019;23(3):436

  9. Young, M., Aldredge, L. and Parker, P. (2017), Psoriasis for the primary care practitioner. Journal of the American Association of Nurse Practitioners, 29: 157-178. https://doi.org/10.1002/2327-6924.12443

  10. Erica B. Lee, BS; Kevin K. Wu, BA; Michael P. Lee, BS; Tina Bhutani, MD; Jashin J. Wu, MD (2018) Psoriasis Risk Factors and Triggers. Cutis. VOL. 102 NO. 5S

  11. Stephen M. Schleicher,Psoriasis: Pathogenesis, Assessment, and Therapeutic Update (2016). Clinics in Podiatric Medicine and Surgery,Volume 33, Issue 3 http://dx.doi.org/10.1016/j.cpm.2016.02.004

  12. Karl T. Clebak, MD, FAAFP; Leesha Helm, MD, MPH; Matthew F. Helm, MD; Elizabeth V. Seiverling, MD (2020).The many variants of psoriasis. THE JOURNAL OF FAMILY PRACTICE, VOL 69, NO 4

  13. Alisa Brandon, Asfandyar Mufti, R. Gary Sibbald (2019) Diagnosis and Management of Cutaneous Psoriasis: A Review. Advances in Skin and Wound Care, VOL. 32 NO. 2

  14. Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019). Risk Factors for the Development of Psoriasis. International Journal of Molecular Sciences, 20(18), 4347. https://doi.org/10.3390/ijms20184347

  15. Lionel Fry, Barbara S. Baker, Triggering psoriasis: the role of infections and medications, Clinics in Dermatology, Volume 25, Issue 6, 2007, Pages 606-615, ISSN 0738-081X.

  16. Kluger, N., Estève, E., Fouéré, S., Dupuis-Fourdan, F., Jegou, M.-H. and Lévy-Rameau, C. (2017), Tattooing and psoriasis: a case series and review of the literature. Int J Dermatol, 56: 822-827. https://doi.org/10.1111/ijd.13646

  17. Elena Pezzolo & Luigi Naldi (2018): The relationship between smoking, psoriasis and psoriatic arthritis, Expert Review of Clinical Immunology, https://doi.org/1080/1744666X.2019.1543591

  18. Whan B. Kim MD Dana Jerome MD MEd FRCPC Jensen Yeung (2017). Diagnosis and management of psoriasis. Canadian Family Physician. VOL 63: APRIL

  19. Barboza Hernández, W. M., & Sobrado Es¬quivel, F. L. Psoriasis: : Revisión bibliográ-fica. Revista Ciencia Y Salud, 5(3), Pág. 52–59. https://doi.org/10.34192/cien-ciaysalud.v5i3.305

  20. I. Belinchón, L. Salgado-Boquete, A. López-Ferrer, M. Ferran, P. Coto-Segura, R. Rivera, D. Vidal, L. Rodríguez, P. de la Cueva, R. Queiro, El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos, Actas Dermo-Sifiliográficas, Volume 111, Issue 10, 2020, Pages 835-846, https://doi.org/10.1016/j.ad.2020.06.004

  21. Shivani P. Reddy,Kathryn Martires,Jashin J. Wu (2017), The risk of melanoma and hematologic cancers in patients with psoriasis, Journal of the American Academy of Dermatology, VOLUME 76, NUMBER 4, http://dx.doi.org/10.1016/j.jaad.2016.09.047

  22. Llamas-Velasco M, et al. Psoriasis moderada. Propuesta de definición. Actas Dermosifiliogr. 2017. http://dx.doi.org/10.1016/j.ad.2017.07.002

  23. Pi Zhang, P., Wu, M.X. A clinical review of phototherapy for psoriasis. Lasers Med Sci 33, 173–180 (2018). https://doi.org/10.1007/s10103-017-2360-1

  24. Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475

  25. Kamata, M., & Tada, Y. (2020). Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review. International Journal of Molecular Sciences, 21(5), 1690. https://doi.org/10.3390/ijms21051690




2020     |     www.medigraphic.com